Chugai Pharmaceutical Co., Ltd. (CHGCY)
Growth
Revenue 5Y15.17%
Revenue 3Y19.84%
EPS 5Y41.31%
EPS 3Y48.43%
Dividend 5Y25.42%
Dividend 3Y41.15%
Capital Efficiency
ROIC39.26%
ROE29.40%
ROA21.80%
ROTA22.14%
Capital Structure
Market Cap43.79B
EV0
Cash274.04B
Current Ratio3.21
Debt/Equity0.23
Net Debt/EBITDA-0.53
CHGCY
Income Statement
Select a metric from the list below to chart it
Dec '03
Dec '07
Dec '11
Dec '15
Dec '19
Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3,263.9 | 3,552.5 | 3,843.1 | 3,788.8 | 4,115.6 | 4,466.8 | 5,286.5 | 6,062.8 | 7,702.3 | 8,811.4 | |
Revenue % Chg. | 8.3% | 8.8% | 8.2% | -1.4% | 8.6% | 8.5% | 18.4% | 14.7% | 27.0% | 28.8% | |
Cost of Revenue | 1,440.5 | 1,680.1 | 1,850.8 | 1,910.2 | 1,958.2 | 2,025.0 | 2,049.9 | 2,106.8 | 2,605.1 | 2,880.6 | |
Cost of Revenue % Chg. | 11.5% | 16.6% | 10.2% | 3.2% | 2.5% | 3.4% | 1.2% | 2.8% | 23.7% | 24.7% | |
Gross Profit | 1,823.4 | 1,872.4 | 1,992.3 | 1,878.6 | 2,157.4 | 2,441.8 | 3,236.6 | 3,955.9 | 5,097.2 | 5,930.8 | |
Gross Profit % Chg. | 5.9% | 2.7% | 6.4% | -5.7% | 14.8% | 13.2% | 32.6% | 22.2% | 28.8% | 30.9% | |
Gross Profit Margin | 55.9% | 52.7% | 51.8% | 49.6% | 52.4% | 54.7% | 61.2% | 65.2% | 66.2% | 67.3% | |
Gross Profit Margin % Chg. | -2.2% | -5.7% | -1.6% | -4.4% | 5.7% | 4.3% | 12.0% | 6.6% | 1.4% | 1.6% | |
R&D Expenses | 572.3 | 622.5 | 645.6 | 654.9 | 716.1 | 764.3 | 831.6 | 907.9 | 1,057.8 | 1,095.5 | |
R&D Expenses % Chg. | 34.8% | 8.8% | 3.7% | 1.4% | 9.3% | 6.7% | 8.8% | 9.2% | 16.5% | 7.5% | |
Selling, General, & Admin Expenses | 644.5 | 665.4 | 678.1 | 631.3 | 679.1 | 719.7 | 782.5 | 727.3 | 789.0 | 806.8 | |
Selling, General, & Admin Expenses % Chg. | 371.0% | 3.2% | 1.9% | -6.9% | 7.6% | 6.0% | 8.7% | -7.1% | 8.5% | 5.8% | |
Operating Income | 606.6 | 584.4 | 668.6 | 592.3 | 762.2 | 957.8 | 1,622.5 | 2,320.7 | 3,250.4 | 4,028.5 | |
Operating Income % Chg. | 3.0% | -3.7% | 14.4% | -11.4% | 28.7% | 25.7% | 69.4% | 43.0% | 40.1% | 46.6% | |
Operating Income Margin | 18.6% | 16.5% | 17.4% | 15.6% | 18.5% | 21.4% | 30.7% | 38.3% | 42.2% | 45.7% | |
Operating Income Margin % Chg. | -4.8% | -11.5% | 5.7% | -10.1% | 18.5% | 15.8% | 43.1% | 24.7% | 10.2% | 13.8% | |
Total Other Income/Expenses Net | -13.8 | 2.3 | 3.8 | -18.8 | -14.7 | -22.1 | -20.8 | -23.4 | -19.4 | -19.3 | |
Total Other Income/Expenses Net % Chg. | 64.3% | - | 61.3% | - | 21.9% | 51.0% | 5.9% | 12.5% | 17.4% | 9.0% | |
Income Before Tax | 592.8 | 586.8 | 672.4 | 573.6 | 747.5 | 935.7 | 1,601.6 | 2,297.3 | 3,231.0 | 4,009.2 | |
Income Before Tax % Chg. | 2.2% | -1.0% | 14.6% | -14.7% | 30.3% | 25.2% | 71.2% | 43.4% | 40.6% | 47.0% | |
Income Before Tax Margin | 18.2% | 16.5% | 17.5% | 15.1% | 18.2% | 20.9% | 30.3% | 37.9% | 41.9% | 45.5% | |
Income Before Tax Margin % Chg. | -5.7% | -9.1% | 5.9% | -13.5% | 20.0% | 15.3% | 44.6% | 25.1% | 10.7% | 14.1% | |
Income Tax Expense | 193.1 | 185.6 | 192.0 | 154.7 | 181.0 | 218.6 | 387.8 | 643.0 | 896.7 | 1,152.5 | |
Income Tax Expense % Chg. | -4.8% | -3.9% | 3.5% | -19.4% | 17.0% | 20.8% | 77.4% | 65.8% | 39.5% | 53.4% | |
Net Income | 392.1 | 392.8 | 470.9 | 412.9 | 560.2 | 712.5 | 1,213.9 | 1,654.3 | 2,334.3 | 2,856.6 | |
Net Income % Chg. | 5.6% | 0.2% | 19.9% | -12.3% | 35.7% | 27.2% | 70.4% | 36.3% | 41.1% | 44.6% | |
Net Income Margin | 12.0% | 11.1% | 12.3% | 10.9% | 13.6% | 16.0% | 23.0% | 27.3% | 30.3% | 32.4% | |
Net Income Margin % Chg. | -2.5% | -8.0% | 10.8% | -11.1% | 24.9% | 17.2% | 43.9% | 18.8% | 11.1% | 12.2% | |
Weighted Avg. Shares Out | 3,267.1 | 3,270.3 | 3,274.6 | 3,277.1 | 3,279.2 | 3,282.1 | 3,282.1 | 3,286.9 | 3,288.3 | 3,289.4 | |
Weighted Avg. Shares Out % Chg. | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | - | 0.1% | 0.0% | 0.1% | |
EPS | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.7 | 0.9 | |
EPS % Chg. | 5.5% | 0.1% | 19.7% | -12.4% | 35.6% | 27.1% | 70.2% | 36.2% | 41.0% | 44.5% | |
Weighted Avg. Shares Out Dil | 3,271.1 | 3,275.7 | 3,280.8 | 3,282.0 | 3,284.5 | 3,287.5 | 3,287.5 | 3,290.2 | 3,290.5 | 3,290.7 | |
Weighted Avg. Shares Out Dil % Chg. | 0.1% | 0.1% | 0.2% | 0.0% | 0.1% | 0.1% | - | 0.1% | 0.0% | 0.1% | |
EPS Diluted | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.7 | 0.9 | |
EPS Diluted % Chg. | 5.4% | 0.0% | 19.7% | -12.4% | 35.6% | 27.1% | 70.3% | 36.2% | 41.1% | 44.5% | |
Interest Income | - | - | 4.3 | 8.6 | - | - | - | - | - | - | |
Interest Income % Chg. | - | - | - | 98.7% | - | - | - | - | - | - | |
Interest Expense | 0.1 | 0.1 | 0.5 | 0.7 | 0.8 | 0.9 | 1.0 | 0.5 | 0.4 | 0.4 | |
Interest Expense % Chg. | 200.0% | -8.3% | 509.1% | 28.4% | 27.9% | 0.9% | 12.6% | -50.4% | -22.6% | - | |
EBIT | 592.7 | 586.7 | 676.2 | 581.5 | 746.7 | 934.8 | 1,600.7 | 2,296.8 | 3,230.6 | 4,008.7 | |
EBIT % Chg. | 1.7% | -1.0% | 15.3% | -14.0% | 28.4% | 25.2% | 71.2% | 43.5% | 40.7% | 47.0% | |
EBIT Margin | 18.2% | 16.5% | 17.6% | 15.3% | 18.1% | 20.9% | 30.3% | 37.9% | 41.9% | 45.5% | |
EBIT Margin % Chg. | -6.1% | -9.1% | 6.5% | -12.8% | 18.2% | 15.3% | 44.7% | 25.1% | 10.7% | 14.1% | |
Depreciation & Amortization | 111.6 | 114.6 | 119.9 | 126.1 | 125.8 | - | - | - | - | - | |
Depreciation & Amortization % Chg. | -5.5% | 2.7% | 4.6% | 5.2% | -0.2% | - | - | - | - | - | |
EBITDA | 704.3 | 701.3 | 796.1 | 707.6 | 872.5 | 934.8 | 1,600.7 | 2,296.8 | 3,230.6 | 4,008.7 | |
EBITDA % Chg. | 0.5% | -0.4% | 13.5% | -11.1% | 23.3% | 7.1% | 71.2% | 43.5% | 40.7% | 47.0% | |
EBITDA Margin | 21.6% | 19.7% | 20.7% | 18.7% | 21.2% | 20.9% | 30.3% | 37.9% | 41.9% | 45.5% | |
EBITDA Margin % Chg. | -7.2% | -8.5% | 4.9% | -9.8% | 13.5% | -1.3% | 44.7% | 25.1% | 10.7% | 14.1% |